Alliance Healthcare donates over 12,000 items of personal protective equipment to charity workers in Leeds

At Alliance Healthcare, we are very proud of the ongoing commitment of our colleagues to support their local communities.

Most recently, team members at our Leeds Service Centre came to the aid of a community charity, The Real Junk Food Project, when it was in need of vital personal protective equipment (PPE) for its volunteers. 

The charity aims to reduce the amount of food entering landfill by redistributing surplus items from supermarkets and restaurants to food banks and primary schools and those in the community in need of it. 

Overall, 12,000 face masks and gloves were donated to the charity, a three-month supply, to enable its volunteers to continue making up hampers of surplus food items and deliver them to local residents. 

In addition, a home delivery driver from our sister company Boots delivered some of the hampers on behalf of The Real Junk Food Project to residents in south Leeds. 

Well done to everyone involved!

From left to right: Ben Gower and Ross Stones

Class 3 Recall - Easyhaler Salbutamol

Orion Corporation T/A Orion Pharma (UK) Ltd are recalling the below batches as a precautionary measure due to an issue related to moulding defects in the bulk chambers where the inhalation powder is stored. There is a risk that the defect possibly presents as a hole in the bulk chamber resulting in the minor loss of inhalation powder. The manufacturer has confirmed that the devices will continue to function correctly with no impact on patient safety

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-easyhaler-salbutamol-sulfate-100-micrograms-per-actuation-slash-200-micrograms-per-actuation-inhalation-powder-el-21-a-slash-06?utm_medium=email&utm_campaign=govuk-notifications&utm_source=43302c1f-c2f7-4a15-ace9-ad4630bf5c67&utm_content=immediately

Further Information

For more information or medical information queries, please contact: UK.MedicalInformation@orionpharma.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

This recall will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 01/06/2021. Please note after this date customer returns may still be accepted but customers may not be credited.

FIELD SAFETY NOTICE - AQUACEL EXTRA 15CMSQ

ConvaTec are voluntarily initiating a field action for the below-stated product because in some instances dressing has been found attached to the seam of the primary packaging therefore breaching the sterile barrier and making the product unable to be used.  Using a non-sterile device on a patient may potentially expose the patient to infectious agents

MHRA drug alert link: N/A

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

This recall will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 16/05/2021. Please note after this date customer returns may still be accepted but customers may not be credited.

CLASS 3 RECALL - CLONIDINE HYDROCHLORIDE 50MICROGRAMS/5ML ORAL SOLUTION

SyriMed are recalling the below batch as a precautionary measure due to an issue related to the container closure (child-lock cap). The Marketing Authorisation Holder has received a number of complaints related to defective container closures and the investigation has identified an issue with the bottle capping during the manufacturing process for this batch only

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-syrimed-clonidine-hydrochloride-50micrograms-slash-5ml-oral-solution-el-21-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications&utm_source=9d29e170-51bd-475e-b98c-3e284cb06be1&utm_content=immediately   

Further Information

For more information or medical information queries, please contact: customer.services@syrimed.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

This recall will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 16/05/2021. Please note after this date customer returns may still be accepted but customers may not be credited.

CLASS 2 RECALL - MIDABUC - MIDAZOLAM (AS HCL) 10MG/ML OROMUCOSAL SOLUTION

: Eaststone Limited has informed us of an issue related to underfilled or empty bottles for MidaBuc - Midazolam (as HCL) 10mg/mL Oromucosal Solution. The below batch is being recalled as a precautionary measure following customer complaints

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-eaststone-limited-midabuc-midazolam-as-hcl-10mg-slash-ml-oromucosal-solution-el-21-a-slash-04?utm_medium=email&utm_campaign=govuk-notifications&utm_source=08ba5ead-1c0a-467b-b061-951a4cff9bb4&utm_content=immediately

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

Further Information

For more information or medical information queries please contact Eaststone at specials@eaststone.co.uk or alternatively call 0800 678 3102.

Walgreens Boots Alliance’s 2020 CSR Report launch, “Health and Humanity: Lessons from the Global Frontline”.

Walgreens Boots Alliance (WBA) launched its 2020 CSR Report via a virtual event: “Health and Humanity: Lessons from the Global Frontline”.

The COVID-19 pandemic meant that 2020 was a year like no other. On Wednesday 10 February, colleagues from Alliance Healthcare in the UK took a moment to recognise their commitment to help people across the UK lead healthier and happier lives and support the Walgreens Boots Alliance sustainability agenda and global force for good.

Thousands of viewers, from more than 30 countries, tuned in to hear about the impact WBA is making in our communities and beyond. The event was an exceptional showcase of how WBA is a force for good in so many ways.

The full broadcast is now available on the WBA corporate website, through social networks Twitter and LinkedIn, and on Bloomberg Live channels (website, YouTube, Twitter, LinkedIn and Instagram).

To download and view WBA’s 2020 CSR Report, please click here.

Contents of the report include:

• Videos about our partnerships with Vitamin Angels, the Leukemia & Lymphoma Society, Macmillan Cancer Support, The Hygiene Bank, Get a Shot. Give a Shot., Red Nose Day and more
• Photos from the CSR report
• LinkedIn, Twitter and Instagram graphics that celebrate WBA’s CSR partnerships and milestones
• Animated GIFs highlighting WBA’s CSR partnerships and commitments

Watch a video now and take a look back with us on a year like no other.

Class 4 Drug Caution in use - AMBISOME LIPOSOMAL 50 MG POWDER FOR DISPERSION FOR INFUSION

Gilead Sciences Ltd has informed us of a quality defect issue, in relation to specific lots of 5µm sterile filters, which are co-packed in cartons of the AmBisome product. The medical device is called Minisart Filter 16534-K

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ambisome-liposomal-50-mg-powder-for-dispersion-for-infusion-pl-16807-slash-0001-el-21-a-slash-03?utm_medium=email&utm_campaign=govuk-notifications&utm_source=b511116a-dcc6-4c20-ab3a-38f79ce58479&utm_content=immediately

Alliance healthcare do not stock this product therefore we are not accepting stock returns.

For more information or medical information queries, please contact:

Gilead Sciences Ltd Medical Information Telephone: +44 (0) 8000 113700 E-mail: ukmedinfo@gilead.com

For stock control queries, please contact:

Customer Care direct line: +44 (0)203 681 4681 E-mail: UKCustomer.Services@gilead.com

CLASS 2 RECALL - PALEXIA ORAL SOLUTION 20MG/1ML

Grünenthal Ltd has informed us of a potential microbial contamination during routine stability testing for the batches listed in this recall. Due to the detection of possible Burkholderia contaminans the batches listed are being recalled as a precautionary measure. Burkholderia contaminans is a gram-negative bacterium and any potential infection may be more serious for immunocompromised patients and patients suffering from cystic fibrosis. This recall affects all batches of oral solution in the UK market that are still within their expiry date

This product is a Schedule 2 Controlled Drug, so please use the Returns Portal for any recalled stock you may need to return to ensure there is authorisation to return. If you are unable to use the Returns Portal please call Customer Services for assistance.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-grunenthal-ltd-palexia-20-mg-slash-ml-oral-solution-pl-21727-slash-0054?utm_medium=email&utm_campaign=govuk-notifications&utm_source=ec81d6b3-a9c2-4242-ad66-27309a75a6fb&utm_content=immediately  

Further Information

For more information or medical information queries please contact +44 (0) 870 351 8960

medicalinformationuk@grunenthal.com

Grünenthal Ltd,1 Stokenchurch Business Park Ibstone Road HP14 3FE

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

This recall will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 08/05/2021. Please note after this date customer returns may still be accepted but customers may not be credited.

Alliance Healthcare continues its support in the fight against cancer

Today is World Cancer Day - a day that unites people, communities and the world by raising cancer awareness.

At Alliance Healthcare, we are proud of how we have been supporting the fight against cancer through Alcura, our patient care business, and the dedicated fundraising support of our employees.

We may be in the process of battling COVID-19 but every working day we continue to deliver approximately 16,500 oncology medicines. Through our Alcura services we deliver a range of oncology medicines and cancer treatments.

Our team of dedicated oncology nurses continues to provide vital homecare support to over 100 patients as part of their cancer treatment. The nurses are qualified to administer a range of oncology drugs, post chemotherapy, to help prevent the reoccurrence of cancer, as well as provide holistic support, including telephone counselling, to help patients manage the side effects of chemotherapy.

Paul Robinson, National Nurse Manager, says: “When we first meet a patient, they are usually very poorly and recovering from months of gruelling chemotherapy and often need lots of reassurance and support.  As cancer nurses we can give the support they need and in this way, a trusting relationship develops.”

Since 2012 Alliance Healthcare has raised and donated over £900k for EORTC Cancer Research Fund . Our dedicated employees have been instrumental in achieving this by organising and taking part in a number of fundraising activities including an annual football and netball tournament, kayaking, cycling and hiking challenges, half marathons and marathons, family fun days, bake sales and quiz nights, and more!

Even through COVID-19 our teams have maintained that support by joining in with an Easter egg competition, photo competitions, lockdown lottos and raffles – and all in a COVID-secure way.

At Alliance Healthcare, we are committed to continue fighting for a cancer-free future.

Alliance Healthcare team members:

Clockwise from top left: Emma Cooper, Emma Crake, Joanne Aspinall, Steve Smith, Ben Miles, David Wood, Ryan Newell, Kunal Nath. Tasnim Ali, Clare Pretty and Janice Clarke, Matt Addison, Krystian Zurawski, Georgia Unsworth

Alucura National Nurse Manager, Paul Robinson

CLASS 3 RECALL - KOLANTICON GEL 500ML

Intrapharm Laboratories Ltd has received a number of complaints that the product consistency is lumpy. The investigation has confirmed through review of the retained samples that the consistency of the complaint samples are similar and the retained samples for this batch show the same homogeneity issue

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-intrapharm-laboratories-ltd-kolanticon-gel-500ml-el-21-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications&utm_source=1c3cadd1-c259-4e77-b3e8-c13faf584fe2&utm_content=immediately  

For more information or medical information queries, please contact: medinfo@intrapharmlabs.com or telephone +44 (0)330 1359 437.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.